Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (83)

2024

  1. Automatic Segmentation and Quantification of Nigrosome-1 Neuromelanin and Iron in MRI: A Candidate Biomarker for Parkinson's Disease

    Journal of Magnetic Resonance Imaging, Vol. 60, Núm. 2, pp. 534-547

  2. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2023

  1. Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 4949-4963

2022

  1. Neurogenetic traits outline vulnerability to cortical disruption in Parkinson's disease

    NeuroImage: Clinical, Vol. 33

  2. Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism

    Brain, Vol. 145, Núm. 6, pp. 2092-2107

2021

  1. Brain Activity and Functional Connectivity Patterns Associated With Fast and Slow Motor Sequence Learning in Late Middle Adulthood

    Frontiers in Aging Neuroscience, Vol. 13

  2. Imaging of Stroke in Rodents Using a Clinical Scanner and Inductively Coupled Specially Designed Receiver Coils

    Annals of Biomedical Engineering, Vol. 49, Núm. 2, pp. 746-756

  3. Neuroplasticity during the transition period: How the adolescent brain can recover from aphasia. A pilot study

    Brain and Development, Vol. 43, Núm. 4, pp. 556-562

  4. Oligodendrocytes, a New Player in the Etiology of Parkinson's Disease

    Movement Disorders

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3

  2. Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 2, pp. 437-450

  3. An application of generalized matrix learning vector quantization in neuroimaging

    Computer Methods and Programs in Biomedicine, Vol. 197

  4. Brain ventricular enlargement in human and murine acute intermittent porphyria

    Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223

  5. Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)

    Psychopharmacology

  6. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  7. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

  8. Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease

    Movement Disorders, Vol. 35, Núm. 2, pp. 316-325

  9. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade

    Scientific Reports, Vol. 10, Núm. 1

  10. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats

    Psychopharmacology, Vol. 237, Núm. 8, pp. 2419-2431

  11. [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 11, pp. 2602-2612